BIBLIOGRAPHIE

2. Aicardi J, Chevrie JJ. Convulsive status epilepticus in infants and children. Epilepsia 1970; 11: 187-197.

3. Dunn DW. Status epilepticus in children : etiology, clinical features and outcome. J. Child Neurol. 1988; 3 : 167-173.

4. Gross Tsur V, Shinnar S. Convulsive status epilepticus in children. Epilepsia 1993; 34 (Suppl1) : S12-S20.

5. Hauser WA. Status epilepticus : Epidemiologic considerations. Neurology 1990; 40 (Suppl 2) : S9-S13.

6. Maytal J, Shinnar S, Moshé SL, Alvarez LA. Low morbidity and mortality of status epilepticus in children. Pediatrics 1989; 83 : 323-331.

7. Wasterlain C, Ed. Status Epilepticus. Sous presse. Raven Press, New York, 1999.

8. Wasterlain CG, Fujikawa DG, Penix L, and Sankar R. Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia 1993, 34 (Suppl 1) : S37-S53.

9. Evrard P, Arzimanoglou A, Husson H, Gressens P, and Sankar R. Management of status epilepticus in the pediatric age group. In : Wasterlain C, Ed. Status Epilepticus. Sous presse. Raven Press, Publ., New York, 1999, sous presse.

10. Husson I, Arzimanoglou A, Gressens P, Evrard P. L’état de mal épileptique. In : Progrès en Neuropédiatrie (P. Evrard et M. Tardieu, éditeurs scientifiques), Collection Progrès en Pédiatrie, Doin, Paris, 2000.

11. Shorvon S. Status epilepticus; its clinical features and treatment in children and adults. Cambridge University Press, Publ., Cambridge, UK, 1994 : 382 pages.

12. Irwin K, Edwards M, and Robinson R. Psychogenic non-epileptic seizures; management and prognosis. Dev Med Child Neurol 1998, 79 (Suppl 1): S11-S12.

13. Alldredge BK, Wall DB, Ferriero DM. Effect of prehospital treatment on the outcome of status epilepticus in children. Pediatric Neurology 1995, 12: 213-216

14. Amand G and Evrard P. Le lorazepam injectable dans les états de mal épileptiques. Rev EEG Neurophysiol 1976; 6: 532-533.

15. Appleton R, Sweeney A, Choonara I, Robson J, and Molyneux E. Lorazepam versus diazepam in the acute treatment of epileptic seizures and status epilepticus. Dev Med Child Neurol 1995; 37: 682-688.

16. Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, Handforth A, Faught E, Calabrese VP, Uthman BM, Ramsay RE, and Mamdani MB. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998, 339: 792-798.

17. Bac P, Maurois P, Dupont C, Pages N, Stables JP, Gressens P, Evrard P, Vamecq J. Magnesium deficiency-dependent audiogenic seizures (MDDAS) in adult mice : a nutritional model for discriminatory screening of anticonvulsivant drugs and original assessment of neuroprotection properties. J. Neurosci., 1998,  18: 4363-4373.

18. Walton NY, Treiman DM. Rational polytherapy in the treatment of status epilepticus. Epilepsy Res Suppl 1996, 11 :123-139.

19. Aicardi J, Chevrie JJ. Consequences of status epilepticus in infants and children. In: Delgado-Escueta AV, Wasterlain C, Treiman DM, Porter RJ (Eds). Status Epilepticus (Advances in Neurology. Vol. 34). 1983 Raven Press, Publ., New York : pp. 115-125.

20. Pellock JM. Fosphenytoin use in children. Neurology 1996, 46 (Suppl 1): S14-S16

21. Wilder BJ (Ed.). The use of parenteral antiepileptic drugs and the role for fosphenytoin. Neurology 1996, 46 (Suppl 1): S1-S2.

22. Takeoka M, Krishnamoorthy KS, Soman TB, and Caviness VS. Fosphenytoin in infants. J Child Neurol 1998; 13: 537-540.

23. Redecker C, Hagemann G, Marret S, Evrard P, Witte OW, and Gressens P. Long-term evolution of excitotoxic cortical dysgenesis induced in the developing rat brain. Dev Brain Res 1998 : 109-113.

24. Ellinwood EH, Heatherly DG, Nikaido AM, Bjornsson TD, and Kilts C. Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam. Psychopharmacology 1985, 86: 392-399.

25. Mitchell WG and Crawford T. Lorazepam is the treatment of choice for status epilepticus. J Epilepsy 1990, 3: 7-10.

26. Thomas P, Arzimanoglou A. Etats de mal épileptiques. In : Epilepsies. Masson eds. 1999 (sous presse)

27. Browne TR. Pharmacology and pharmacokinetics of fosphenytoin. Neurology 1996, 46 (Suppl 1): S3-S7.

28. Ramsay RE, De Toledo J. Intravenous administration of fosphenytoin : options for management of seizures. Neurology 1996, 46 (Suppl 1): S17-S19.

29. Treiman DM, De Giorgio CH, Salisbury S, Wickboldt C. Subtile generalized convulsive status epilepticus. Epilepsia 1984; 25 : 653.

30. Browne TR. Paraldehyde, chlormethiazole, and lidocaine for treatment of status epilepticus. In : Delgado-Escueta AV, Wasterlain CG, Treiman DM et al. (eds.) Status epilepticus (Advances in Neurology, vol 34), 1983 New York, Raven Press : pp 509-517.

31. Delgado-Escueta AV, Wasterlain CG, Treiman DM et al. Management of status epilepticus. N Engl J Med 1982; 306 : 1337-1340.

32. Harrison AM, Lugo RA, Schunck JE. Treatment of convulsive status epilepticus with propofol: case report. Pediatr Emerg Care 1997; 13: 420-422.

33. Black S, Mahla MF, and Cucchiara RF. Monitorage neurologique. In: Miller RD (Ed.). Anesthésie (4e ed). Médecine-Sciences, Flammarion, Publ., Paris, 1966, pages 1319-1328.

34. Aicardi J. Diseases of the nervous system in childhood. Mac Keith Press & Cambridge University Press, London 1998 : 897 pages.

35. Aicardi J. Epilepsy in Children (2nd Ed.) ICNA Series. Raven Press, New York, 1994.

36. Lyon G et Evrard P. Neuropédiatrie, 2ème édition. Masson, Publ. Paris, 1999, sous presse.

37. Graves NM, Kriel RL, and Jones-Saete C. Bioavailability of rectally administered lorazepam. Clinical Neuropharmacology. 1987, 10: 555-559.

38. Brown JK and Hussain IHMI. Status epilepticus I: Pathogenesis. Dev Med Child Neurol 1991a; 33: 3-17.

39. Brown JK and Hussain IHMI. Status epilepticus II: Treatment. Dev Med Child Neurol  1991b; 33: 97-109.

40. Adams HA and Werner C. From the racemate to the eutomer : (S)-ketamine. Renaissance of a substance ? (article en allemand). Anaesthesist 1997, 46 : 1026-1042.

41. Phillips SA, Shanahan RJ. Etiology and mortality of status epilepticus in children. A recent update. Arch. Neurol. 1989; 46 : 74-76.

42. Brett EM. Paediatric Neurology (3rd Ed.). Churchill Livingstone, London 1997.